Methylmalonic aciduria type A protein (MMAA) (Dobson et al. 2002) is thought to act as a chaperone to MUT and is suggested to play a dual role with regards to MUT protection and reactivation.
Defects in MMAA cause methylmalonic aciduria type cblA (MMAA aka methylmalonic aciduria type A or vitamin B12-responsive methylmalonicaciduria of cblA complementation type; MIM:251100). Affected individuals accumulate methylmalonic acid in the blood and urine and are prone to potentially life threatening acidotic crises in infancy or early childhood (Dobson et al. 2002, Lerner-Ellis et al. 2004).
Dobson, CM, Hudson, T, Doré, C, Gravel, RA, Rosenblatt, DS, Wu, X, Leclerc, D, Wai, T, Wilson, A
Niles, K, Worgan, LC, Rosenblatt, DS, Lepage, P, Hofmann, A, Kucic, T, Tirone, JC, Sammak, A, Verner, A
Dobson, CM, Doré, C, Gravel, RA, Rosenblatt, DS, Lepage, P, Leclerc, D, Watkins, D, Wai, T, Tirone, JC, Lerner-Ellis, JP
Jansen, R, Rosenberg, LE, Kalousek, F, Ledley, FD, Fenton, WA
molecular carrier activity of 2xMMAA:2xMUT [mitochondrial matrix]
© 2025 Reactome